M&A Deal Summary

Integra LifeSciences Holdings Acquires Confluent Surgical

On October 28, 2013, Integra LifeSciences Holdings acquired medical products company Confluent Surgical from Covidien for 265M USD

Acquisition Highlights
  • This is Integra LifeSciences Holdings’ 32nd transaction in the Medical Products sector.
  • This is Integra LifeSciences Holdings’ 4th largest (disclosed) transaction.
  • This is Integra LifeSciences Holdings’ 30th transaction in the United States.
  • This is Integra LifeSciences Holdings’ 5th transaction in Massachusetts.

M&A Deal Summary

Date 2013-10-28
Target Confluent Surgical
Sector Medical Products
Buyer(s) Integra LifeSciences Holdings
Sellers(s) Covidien
Deal Type Divestiture
Deal Value 265M USD

Target

Confluent Surgical

Waltham, Massachusetts, United States
Confluent Surgical, Inc.develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Integra LifeSciences Holdings

Princeton, New Jersey, United States

Category Company
Founded 1989
Sector Medical Products
Employees3,946
Revenue 1.5B USD (2023)
DESCRIPTION

Integra LifeSciences Holdings is a major medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra LifeSciences Holdings was founded in 1989 and is based in Princeton, New Jersey.


DEAL STATS #
Overall 37 of 45
Sector (Medical Products) 32 of 38
Type (Divestiture) 9 of 12
State (Massachusetts) 5 of 8
Country (United States) 30 of 38
Year (2013) 3 of 3
Size (of disclosed) 4 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-28 Covidien - DuraSeal Product Lines

Dublin, Ireland

Covidien plc - DuraSeal(TM) Product Lines includes surgical sealants, adhesion barrier, and, most importantly, DuraSeal™.

Buy $235M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-27 Medtronic - MicroFrance and Xomed Business

United States

The MicroFrance business, which includes Xomed's manual ENT instruments, designs, manufactures and sells reusable handheld instruments to ear, nose and throat ("ENT") and laparoscopy surgical specialists.

Buy $60M

Seller(S) 1

SELLER

Covidien

Dublin, Ireland

Category Company
Sector Medical Products
Employees38,500
Revenue 10.2B USD (2013)
DESCRIPTION
Covidien office in Plymouth, Minnesota.
Covidien office in Plymouth, Minnesota.

Covidien plc is a global healthcare technology and medical supplies provider. Covidien was formed as a spin-off from Tyco in 2007 and is based in Dublin, Ireland.


DEAL STATS #
Overall 3 of 4
Sector (Medical Products) 2 of 3
Type (Divestiture) 2 of 3
State (Massachusetts) 1 of 1
Country (United States) 1 of 2
Year (2013) 3 of 3
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-28 Covidien - DuraSeal Product Lines

Dublin, Ireland

Covidien plc - DuraSeal(TM) Product Lines includes surgical sealants, adhesion barrier, and, most importantly, DuraSeal™.

Sell $235M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-13 Given Imaging

Yoqneam, Israel

Given Imaging Ltd. ,creates innovative solutions that meet the needs of patients. To do so, we continuously work to develop and provide physicians with innovative tools that enable them to make decisions about their patients’ health.

Buy $860M